47. Rasmussen K, Jacobs BL. Single unit activity of locus
coeruleus neurons in the freely moving cat. II. Con-
ditioning and pharmacologic studies. Brain Res 371,
335–344, 1986.
48. Steininger TL, Alam MN, Gong H, et al. Sleep-
waking discharge of neurons in the posterior lateral
hypothalamus of the albino rat. Brain Res 840, 138–
147, 1999.
49. Wu MF, John J, Boehmer LN, et al. Activity of dorsal
raphe cells across the sleep-waking cycle and during
cataplexy in narcoleptic dogs. J Physiol 554, 202–215,
2004.
50. Kolta A, Reader TA. Modulatory effects of catechol-
amines on neurons of the rat visual cortex: single-cell
iontophoretic studies. Can J Physiol Pharmacol 67,
615–623, 1989.
51. Sato H, Fox K, Daw NW. Effect of electrical stimu-
lation of locus coeruleus on the activity of neurons in
the cat visual cortex. J Neurophysiol 62, 946–958, 1989.
52. Bassant MH, Ennouri K, Lamour Y. Effects of ion-
tophoretically applied monoamines on somatosensory
cortical neurons of unanesthetized rats. Neuroscience
39, 431–439, 1990.
53. Lu J, Sherman D, Devor M, et al. A putative flip-flop
switch for control of REM sleep. Nature 441, 589–
594, 2006.
54. Saper CB. Diffuse cortical projection systems: anato-
mical organization and role in cortical function. In:
F. Plum, ed. Handbook of Physiology. The Nervous
System. V. Bethesda, Md.: American Physiological So-
ciety, pp 168–210, 1987.
55. Welch MJ, Meltzer EO, Simons FE. H1-antihistamines
and the central nervous system. Clin Allergy Immunol
17, 337–388, 2002.
56. Huang ZL, Qu WM, Li WD, et al. Arousal effect of
orexin A depends on activation of the histaminergic
system. Proc Natl Acad Sci 98, 9965–9970, 2001.
57. Parmentier R, Ohtsu H, Djebbara-Hannas Z, et al.
Anatomical, physiological, and pharmacological char-
acteristics of histidine decarboxylase knock-out mice:
evidence for the role of brain histamine in behavioral
and sleep-wake control. J Neurosci 22, 7695–7711,
2002.
58. Peyron C, Tighe DK, van den Pol AN, et al. Neurons
containing hypocretin (orexin) project to multiple neu-
ronal systems. J Neurosci 18, 9996–10015, 1998.
59. Bittencourt JC, Frigo L, Rissman RA, et al. The dis-
tribution of melanin-concentrating hormone in the
monkey brain (Cebus apella). Brain Res 804, 140–143,
1998.
60. Bittencourt JC, Presse F, Arias C, et al. The melanin-
concentrating hormone system of the rat brain: an
immuno- and hybridization histochemical character-
ization. J Comp Neurol 319, 218–245, 1992.
61. Lin CS, Nicolelis MA, Schneider JS, et al. A major
direct GABAergic pathway from zona incerta to neo-
cortex. Science 248, 1553–1556, 1990.
62. Lee MG, Hassani OK, Jones BE. Discharge of iden-
tified orexin/hypocretin neurons across the sleep-
waking cycle. J Neurosci 25, 6716–6720, 2005.
63. Mileykovskiy BY, Kiyashchenko LI, Siegel JM. Behav-
ioral correlates of activity in identified hypocretin/
orexin neurons. Neuron 46, 787–798, 2005.
64. Verret L, Goutagny R, Fort P, et al. A role of
melanin-concentrating hormone producing neurons
in the central regulation of paradoxical sleep. BMC
Neurosci 4, 19, 2003.
65. Alam MN, Gong H, Alam T, et al. Sleep-waking dis-
charge patterns of neurons recorded in the rat peri-
fornical lateral hypothalamic area. J Physiol 538, 619–
631, 2002.
66. Gelineau JBE. De la narcolepsie. Gaz Hop (Paris)
53, 626–637, 1880.
67. Sakurai T, Amemiya A, Ishii M, et al. Orexins and
orexin receptors: a family of hypothalamic neuropep-
tides and G protein-coupled receptors that regulate
feeding behavior. Cell 92, 573–585, 1998.
68. de Lecea L, Kilduff TS, Peyron C, et al. The hypo-
cretins: hypothalamus-specific peptides with neuro-
excitatory activity. Proc Natl Acad Sci 95, 322–327,
1998.
69. Willie JT, Chemelli RM, Sinton CMYM. To eat or to
sleep? Orexin in the regulation of feeding and wake-
fulness. Annu Rev Neurosci 24, 429–458, 2001.
70. Chimelli RM, Willie JT, Sinton CM, et al. Narcolepsy
in orexin knockout mice: molecular genetics of sleep
regulation. Cell 98, 437–451, 1999.
71. Lin L, Faraco J, Li R, et al. The sleep disorder canine
narcolepsy is caused by a mutation in the hypocretin
(orexin) receptor 2 gene. Cell 98, 365–376, 1999.
72. Peyron C, Faraco J, Rogers W, et al. A mutation in a
case of early onset narcolepsy and a generalized ab-
sence of hypocretin peptides in human narcoleptic
brains. Nat Med 6, 991–997, 2000.
73. Ripley B, Overeem S, Fujiki N, et al. CSF hypocretin/
orexin levels in narcolepsy and other neurological con-
ditions. Neurology 57, 2253–2258, 2001.
74. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced
number of hypocretin neurons in human narcolepsy.
Neuron 27, 469–474, 2000.
75. Marcus JN, Aschkenasi CJ, Lee CE, et al. Differential
expression of orexin receptors 1 and 2 in the rat brain.
J Comp Neurol 435, 6–25, 2001.
76. Saper CB. Organization of cerebral cortical afferent
systems in the rat. II. Magnocellular basal nucleus.
J Comp Neurol 222, 313–342, 1984.
77. Zaborsky L, Brownstein MJ, Palkovits M. Ascending
projections to the hypothalamus and limbic nuclei
from the dorsolateral pontine tegmentum: a biochem-
ical and electron microscopic study. Acta Morphol
Acad Sci Hung 25, 175–188, 1977.
78. Zaborsky L, Cullinan WE, Luine VN. Catecholami-
nergic-cholinergic interaction in the basal forebrain.
Prog Brain Res 98, 31–49, 1993.
79. Lee MG, Hassani OK, Alonso A, et al. Cholinergic
basal forebrain neurons burst with theta during
waking and paradoxical sleep. J Neurosci 25, 4365–
4369, 2005.
80. Richardson RT, DeLong MR. Nucleus basalis of
Meynert neuronal activity during a delayed response
task in monkey. Brain Res 399, 364–368, 1986.
81. Richardson RT, DeLong MR. Context-dependent
responses of primate nucleus basalis neuron in a go/
no-go-go task. J Neurol Sci 10, 2528–2540, 1990.
82. Sherin JE, Shiromani PJ, McCarley RW, et al. Acti-
vation of ventrolateral preoptic neurons during sleep.
Science 271, 216–219, 1996.
83. Sherin JE, Elmquist JK, Torrealba F, et al. Inner-
vation of histaminergic tuberomammilary neurons
by GABAergic and alaninergic neurons in the ven-
36
Plum and Posner’s Diagnosis of Stupor and Coma